300+ investors in your industry, stage, and region Get
Any industry
Hospitality
Video Games
EdTech
Restaurants
Google
Construction
Photography
Cryptocurrency
Clean Energy
CleanTech
Big Data
Email
Social Impact
Energy
SaaS
Mobile
Consumer
Health Care
Enterprise Software
Local
Platforms
Travel
InsurTech
Artificial Intelligence
Oil and Gas
Payments
Retail
Film
Marketplace
Organic Food
Fitness
Machine Learning
Agriculture (AgTech)
Gaming
Social Network
B2B
Wellness
Education
Medical Device
Automotive
eSports
Sports
Legal
Biotechnology
Renewable Energy
Facebook
Software
Medical
Web3
Theatre
Recruiting
Crowdfunding
Infrastructure
Venture Capital
Beauty
Fashion
Social
Celebrity
LGBT
Climate
Cannabis
Wine and Spirits
Mobile Apps
Life Science
Food and Beverage
Publishing
Art
Music
Real Estate
Sporting Goods
FinTech
Finance
Digital Media
Manufacturing
Social Media
Financial Services
Franchise
Non Profit
Internet
Mobile Advertising
Android
Sustainability
Proptech
Hardware
Impact
Transportation
Biotech
Enterprise
Community
Media (Entertainment)
Blockchain
Any country
Afghanistan
Greece
United Kingdom
Thailand
United Arab Emirates
Andorra
Benin
Japan
South Korea
Singapore
Burkina Faso
LATAM
Brazil
Africa
Gibraltar
Egypt
Oceania
Taiwan
Zimbabwe
Hong Kong
Tunisia
Sweden
Nigeria
Togo
Croatia
Iran
Guinea
Kyrgyzstan
Haiti
Norway
Lesotho
Isle of Man
Liberia
Malawi
Nepal
Mexico
Madagascar
Russian Federation
Sudan
Pakistan
Tajikistan
Zambia
Oman
Romania
Puerto Rico
Poland
Guernsey
Cameroon
Colombia
China
Armenia
Costa Rica
Czech Republic
Marshall Islands
Kuwait
Luxembourg
Malta
Namibia
Mozambique
Mauritius
Nicaragua
Panama
Serbia
Uzbekistan
Australia
New Zealand
Morocco
Jamaica
Sri Lanka
Switzerland
Guatemala
Kazakhstan
Cayman Islands
Venezuela
Uganda
Myanmar
Turkey
Uruguay
Seychelles
Moldova
Paraguay
Botswana
South Africa
France
Denmark
Georgia
Ghana
Iraq
Portugal
Philippines
Sierra Leone
El Salvador
Senegal
India
Germany
Canada
Ireland
Saudi Arabia
Latvia
Kenya
Mali
Malaysia
Rwanda
Tanzania
United States
Middle East
Indonesia
Bermuda
Dominican Republic
Asia
Albania
Angola
Europe
Argentina
Cyprus
Spain
Qatar
Barbados
Belgium
Austria
Ethiopia
Jordan
Azerbaijan
Ecuador
Bulgaria
Faroe Islands
Estonia
Bahrain
Bahamas
Jersey
Bolivia
Belize
Algeria
Belarus
Finland
Italy
Hungary
Israel
Grenada
Honduras
Iceland
Lithuania
Cambodia
Liechtenstein
Lebanon
Mongolia
Bangladesh
Peru
Slovenia
San Marino
Ukraine
Chile
Vietnam
Angel Investors
VC Funds
All Investors
Download Find emails Save list
Open database

Top 35 Life Science VC Funds & Investors in Singapore (October 2026)

The most active venture capital funds investing in Singapore Life Science startups. This investor list is updated monthly from the Shizune investor database, ranked by number of investments in Singapore Life Science startup companies. Find investors to raise a Seed, Series A or Series B round with Shizune.
Investor Relevant Deals Geography Stage Focus Round Size
EDBI
VC Fund
3 United States, Singapore, United Kingdom Series C, Series B, Series D Software, Biotechnology, Health Care $10M–$400M
UTEC - The University of Tokyo Edge Capital Partners
VC Fund
3 Japan, United States, India Series A, Seed, Venture - Series Unknown Health Care, Biotechnology, Medical $624k–$18M
Anzu Partners
VC Fund
3 United States, Canada, Spain Series A, Series B, Venture - Series Unknown Software, Biotechnology, Manufacturing $5M–$44M
Antler
VC Fund
3 United States, Singapore, Australia Pre-Seed, Seed, Series A Software, Artificial Intelligence, Information Technology $100k–$29M
Temasek
VC Fund
2 United States, China, India Series B, Series C, Series D Biotechnology, Health Care, Software $28M–$460M
Bossa Invest
VC Fund
2 United States, Brazil, Mexico Seed, Pre-Seed, Venture - Series Unknown Software, Information Technology, Financial Services $49k–$36M
Eisai
VC Fund
2 Japan, United States, China Series A, Series C, Grant Medical, Biotechnology, Health Care $881k–$100M
Partners Investment
VC Fund
2 South Korea, United States, Japan Series A, Series B, Series C Biotechnology, Health Care, Software $2.4M–$98M
Accel X
VC Fund
1 Singapore Seed, Series A Shopping, Analytics, E-Commerce $600k–$14M
SK Securities
VC Fund
1 South Korea, United States, Singapore Series A, Seed, Series B Information Technology, Health Care, Artificial Intelligence $316k–$24M
Alameda Research
VC Fund
1 United States, Singapore, United Kingdom Seed, Venture - Series Unknown, Series A Blockchain, Cryptocurrency, Financial Services $250k–$40M
Shinhan Investment
VC Fund
1 South Korea, United States, Bermuda Series A, Series B, Series C Health Care, Manufacturing, Information Technology $20k–$106M
The Venture Collective
VC Fund
1 United States, United Kingdom, Germany Seed, Series A, Pre-Seed Health Care, Biotechnology, Artificial Intelligence $410k–$52M
Altara Ventures
VC Fund
1 Indonesia, Singapore, Philippines Series A, Series B, Series C FinTech, Information Technology, Banking $3.9M–$70M
Hana Financial Investment
VC Fund
1 South Korea, Singapore, India Series A, Series B, Seed Biotechnology, Information Technology, Artificial Intelligence $213k–$28M
Openspace Capital
VC Fund
1 Singapore, Indonesia, Philippines Series A, Series B, Seed E-Commerce, Financial Services, Software $1.7M–$35M
Seeds Capital
VC Fund
1 Singapore, United States, Hong Kong Seed, Series A, Series B Biotechnology, Artificial Intelligence, Health Care $767k–$45M
Nestle
VC Fund
1 United States, United Kingdom, Germany Private Equity, Corporate Round, Grant Food and Beverage, Health Care, Food Processing $6k–$4.2B
KT Investment
VC Fund
1 South Korea, United States, Singapore Series A, Series B, Series C Artificial Intelligence, Software, Information Technology $2M–$124M
Prox Ventures
VC Fund
1 China, United States, United Kingdom Seed, Series A Medical, Biotechnology, Health Care $2.5M–$30M
K3 Ventures
VC Fund
1 Singapore, United States, Indonesia Series A, Seed, Venture - Series Unknown Financial Services, FinTech, Software $1M–$2.5B
Vertex Ventures Southeast Asia & India
VC Fund
1 India, Singapore, Indonesia Series A, Series B, Seed E-Commerce, Financial Services, FinTech $2.2M–$40M
Hatcher+
VC Fund
1 United States, Italy, Australia Pre-Seed, Seed, Convertible Note Software, Information Technology, Health Care $50k–$1.5M
Elev8.VC
VC Fund
1 Singapore, United States, Germany Seed, Series A Health Care, Biotechnology, Medical $1M–$13M
Amgen Ventures
VC Fund
1 United States, Canada, United Kingdom Series B, Series A, Series C Biotechnology, Health Care, Therapeutics $4.4M–$114M
Arche Investment
VC Fund
1 South Korea, Singapore Series B, Series A Biotechnology, Pet, Apps $16M–$27M
KB Financial Group
VC Fund
1 South Korea, India, Vietnam Series A, Series B, Series D Financial Services, Software, SaaS $1M–$220M
Enterprise Singapore
VC Fund
1 Singapore, United States, United Kingdom Grant, Seed, Pre-Seed Information Technology, Software, Artificial Intelligence $22k–$1.8M
Gaorong Capital
VC Fund
1 China, United States, Singapore Series A, Series B, Seed Artificial Intelligence, Information Technology, Software $1.6M–$110M
10X Capital
VC Fund
1 United States, Canada, United Kingdom Seed, Series A, Pre-Seed Software, Health Care, FinTech $800k–$36M
Animoca Brands
VC Fund
1 United States, Singapore, United Kingdom Seed, Series A, Pre-Seed Blockchain, Gaming, Cryptocurrency $100k–$40M
NPR Holdings
VC Fund
1 Singapore Venture - Series Unknown Medical, Life Science, Biotechnology
Lightstone Ventures
VC Fund
1 United States, Ireland, India Series A, Series B, Series C Biotechnology, Health Care, Therapeutics $18M–$105M
Medici Investment
VC Fund
1 South Korea, Canada, Singapore Series A, Series C, Seed Biotechnology, Information Technology, Software $861k–$250M
M Capital Partners
VC Fund
1 France, United States, Canada Venture - Series Unknown, Seed Health Care, Software, Food and Beverage $1.1M–$5.6M
Access all 76 VC funds in Singapore Life Science startups.

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!

Investor list

EDBI
VC Fund · Singapore, Central Region, Singapore · 3 investments in Singapore Life Science startups

EDBI invests in high growth technology sectors. EDBI Creates value and empowers companies to build sustainable legacies.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Health Care
  • Stage:Series C, Series B, Series D
  • Geography: United States, Singapore, United Kingdom

Investor stats

  • Total investments: 205
  • Round size: Series B $19M–$170M; Series C $10M–$275M; Series D $17M–$400M
  • Lead/follow: 22% lead, 78% follow

Portfolio highlights

  • Ivantis — Ivantis, Inc. is a company focused on developing an innovative treatment for Glaucoma. It is their goal to develop a less invasive, more effective option for the 60+ million people worldwide suffering from Primary Open Angle Glaucoma. As they successfully address this initial goal, it is then there intention to focus on innovative development forthe treatment of other debilitating diseases within ophthalmology.
  • TriReme Medical — TriReme Medical, Inc. (TMI) is a privately held medical device company based in Pleasanton, California. Founded in 2005, it is dedicated to the development and manufacturing of novel stent technologies for the treatment of coronary artery disease (CAD) at or near bifurcations.
  • Universal Quantum — Universal Quantum is building quantum computers to tackle real-world problems that would take today’s fastest supercomputers billions of years to solve.
Show all investments...

UTEC - The University of Tokyo Edge Capital Partners
VC Fund · Tokyo, Tokyo, Japan · 3 investments in Singapore Life Science startups

UTEC-The University of Tokyo Edge Capital Partners Co., Ltd.. UTEC is a seed/early stage technology focused venture capital firm associated with The University of Tokyo.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Series A, Seed, Venture - Series Unknown
  • Geography: Japan, United States, India

Investor stats

  • Total investments: 215
  • Round size: Seed $624k–$12M; Series A $2.3M–$18M; Venture - Series Unknown $2.2M–$13M
  • Lead/follow: 37% lead, 63% follow
  • Last fund: Likely actively investing — fresh fund, raised $326M in 2025

Portfolio highlights

  • Mujin — At Mujin, we design automation platforms to enhance any robot, enable advanced capabilities and lower operating costs.
  • RegCell — RegCell aims to generate novel therapeutic technologies through augmenting or controlling the immune system and our goal is to save patients who suffer from autoimmune diseases and cancer .
  • United Immunity — Just another WordPress site
Show all investments...

Anzu Partners
VC Fund · Washington, District of Columbia, United States · 3 investments in Singapore Life Science startups

Anzu Partners invests in breakthrough clean tech, industrial, and life science technologies with $1B in assets under management across venture, credit, and public structures.

Show more...

Investment focus

  • Industry: Software, Biotechnology, Manufacturing
  • Stage:Series A, Series B, Venture - Series Unknown
  • Geography: United States, Canada, Spain

Investor stats

  • Total investments: 84
  • Round size: Series A $6M–$25M; Series B $5M–$44M; Venture - Series Unknown $7M–$21M
  • Lead/follow: 54% lead, 46% follow
  • Last fund: Likely still investing — raised $100M in 2024

Portfolio highlights

  • 6K — WHERE INDUSTRY 4.0 MEETS SUSTAINABLE PRODUCTION OF BREAKTHROUGH MATERIALS
  • EnCharge AI — AI Compute from the Edge-to-Cloud for Every Business. Transformative technology for AI computation, breaking records in efficiency and sustainability to enable state-of-the-art models uninhibited by power, space, and cost constraints.
  • South 8 Technologies — South 8's LiGas cells are engineered to deliver unmatched performance and safety in the most demanding environments.
Show all investments...

Antler
VC Fund · Singapore, Central Region, Singapore · 3 investments in Singapore Life Science startups

Build your next company with Antler, a global day zero investor enabling exceptional founders to start great companies, from the very beginning. Apply now!

Show more...

Investment focus

  • Industry: Software, Artificial Intelligence, Information Technology
  • Stage:Pre-Seed, Seed, Series A
  • Geography: United States, Singapore, Australia

Investor stats

  • Total investments: 2387
  • Round size: Seed $158k–$4.6M; Pre-Seed $100k–$600k; Series A $4.1M–$29M
  • Lead/follow: 43% lead, 57% follow
  • Last fund: Likely actively investing — fresh fund, raised $7.5M in 2026

Portfolio highlights

  • iiba — Iiba is a geospatial platform that specializes in providing location information related to child-rearing.
  • Obud — Obud is a wellness reservation systems that is designed for holistic health and lifestyle management purposes. The company's systems offer a comprehensive suite of tools for booking wellness activities, managing schedules, and accessing curated wellness programs, enabling wellness centers to streamline their operations, enhance userengagement, and promote a balanced and healthy lifestyle.
  • Plouton AI —
Show all investments...

Temasek
VC Fund · Singapore, Central Region, Singapore · 2 investments in Singapore Life Science startups, 46 in the past 12 months

Temasek is a global investment company headquartered in Singapore with a multinational staff of over 960 people. Our portfolio is valued at S$434 billion.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series B, Series C, Series D
  • Geography: United States, China, India

Investor stats

  • Total investments: 669
  • Round size: Series B $29M–$250M; Series C $28M–$400M; Series D $43M–$460M
  • Lead/follow: 46% lead, 54% follow
  • Last fund: May invest from a new fund soon — raised $283M in 2019

Portfolio highlights

  • Vinci — Vinci runs massive simulations at nanometer resolution in minutes, validated for accuracy. The first foundation model for physics.
  • Devoted Health — Devoted Health is a new healthcare company serving seniors. Aiming to launch Medicare Advantage plans in 2019, their mission is to build a healthcare solution good enough for Mom. They will be devoted to the health and wellness of their members by helping them navigate the health care system with personal guides, by utilizing world-class technologyto enable a simplified experience, and by partnering with top providers for better health outcomes.
  • Soufflé Therapeutics — Soufflé Therapeutics is a biotechnology company specializing in the development of nucleic acid medicines designed for precise delivery and targeting of disease-causing cells. The company's mission is to create potent, precise, and safe medicines that can be tailored for a broad range of diseases by leveraging breakthroughs in genetic medicineand drug delivery technology.
Show all investments...

Bossa Invest
VC Fund · São Paulo, Sao Paulo, Brazil · 2 investments in Singapore Life Science startups, 11 in the past 12 months

Aprenda a Investir em Startups

Show more...

Investment focus

  • Industry: Software, Information Technology, Financial Services
  • Stage:Seed, Pre-Seed, Venture - Series Unknown
  • Geography: United States, Brazil, Mexico

Investor stats

  • Total investments: 2097
  • Round size: Seed $166k–$5.8M; Pre-Seed $49k–$2M; Venture - Series Unknown $632k–$36M
  • Lead/follow: 3% lead, 97% follow
  • Last fund: Likely actively investing — fund raised in 2025

Portfolio highlights

  • FFID — FFID develops AI chatbot platform automating customer communication, lead generation, and marketing workflows.
  • SprayX — Company specialized in interactive process control to evaluate and guarantee the quality of agricultural spraying with excellence. Empowers, leads and monitors applicators in Application Technology tasks.
  • Sandwiche — Sandwiche creates customizable link in bio pages enabling social media monetization and affiliate marketing management.
Show all investments...

Eisai
VC Fund · Tokyo, Tokyo, Japan · 2 investments in Singapore Life Science startups

Eisai is a human healthcare company that provides products and services to its patients and their families under any healthcare system. They specialize in an integrated pharmaceutical business that operates in business groups and focuses on oncology and neurology, dementia-related diseases, and neurodegenerative diseases.

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Health Care
  • Stage:Series A, Series C, Grant
  • Geography: Japan, United States, China

Investor stats

  • Total investments: 20
  • Round size: Series A $3M–$51M; Series C $881k–$100M
  • Lead/follow: 50% lead, 50% follow

Portfolio highlights

  • Medefer — At Medefer, we want to be the world’s most patient-focused virtual health serviceWe are on a mission to help patients get better faster. We are starting by partnering with the NHS to build the best outpatient process, helping assess patients more quickly.To do this work with our partners, we provide technology-enabled clinical and operationalexpertise, making it better for patients, healthcare professionals and the NHS.
  • Head Diagnostics — Innovating Brain Health, Transforming Lives. We empower you with clinically validated AI-driven digital solutions designed to support diagnosis and enhance the detection and management of neurological disease with a focus on cognitive assessment
  • Beren Therapeutics — Founded to serve patients through transformative medicines
Show all investments...

Partners Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 2 investments in Singapore Life Science startups, 7 in the past 12 months

As a responsible and long-term partner, they aim to make various constructive contributions to portfolio companies.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Software
  • Stage:Series A, Series B, Series C
  • Geography: South Korea, United States, Japan

Investor stats

  • Total investments: 132
  • Round size: Series A $2.4M–$30M; Series B $5.5M–$98M; Series C $7.4M–$87M
  • Lead/follow: 11% lead, 89% follow
  • Last fund: Likely still investing — raised $190M in 2023

Portfolio highlights

  • XCENA — XCENA is a semiconductor company that develops data-centric computing systems designed for AI and large-scale data processing environments. The company builds computational memory technology that combines high-capacity pooled DDR5 memory with near-data processing capabilities, allowing computation to occur closer to where data is stored. Its coreplatform is based on the Compute Express Link (CXL) standard, which enables memory expansion beyond traditional CPU limitations while improving data movement efficiency and reducing latency in data center workloads. XCENA’s architecture is designed to support applications such as artificial intelligence workloads, vector databases, and large-scale analytics by addressing memory bandwidth and capacity constraints. The company provides a hardware-software ecosystem that includes computational memory systems and a full-stack software development kit. This SDK offers APIs, runtime tools, and drivers that allow applications to use computational memory without major changes to existing software architectures while also supporting low-level control for performance optimization.XCENA’s flagship product line includes MX1, a CXL-based computational memory solution that integrates near-data processing engines with memory infrastructure to support AI inference and data-intensive workloads. The platform is designed to improve throughput and scalability in environments where traditional memory architectures become a bottleneck. The company operates in the broader field of AI infrastructure and memory innovation, working with customers such as hyperscalers, telecom providers, and research institutions that manage large-scale computing workloads. Its solutions are intended to improve efficiency in systems handling AI, big data processing, and scientific computing.
  • Solivis — Solivis is the manufacturer of solid-state batteries designed for next-generation battery packs. The company's product is used as a secondary battery for electric vehicles and has developed a wet synthesis method that can mass-produce a sulfide-based solid electrolyte with homogeneous high ionic conductivity, enabling clients to significantlyimprove productivity by reducing process costs and shortening the synthesis time.
  • Cenyx Biotech — Cenyx Biotech develops diagnostic and therapeutic nano-compounds formed based on nanozymes and nanoparticles.
Show all investments...

Accel X
VC Fund · Singapore, Central Region, Singapore · 1 investments in Singapore Life Science startups

Accel-X Pte Ltd, is a venture capital fund that invests in early stage technology companies that are highly scalable. Led by Mr Edmund Yong, a successful investor and entrepreneur who brings to the table more than 20 years of operational experience. The fund helps technology startups to develop go-to-market strategies, build teams, scale aswell as position themselves for follow-on funding and IPO.

Show more...

Investment focus

  • Industry: Shopping, Analytics, E-Commerce
  • Stage:Seed, Series A
  • Geography: Singapore

Investor stats

  • Total investments: 3
  • Round size: Seed $600k–$14M
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • PatSnap — PatSnap is a connected innovation intelligence platform that provides IP and R&D intelligence. It is used by more than 10,000 customers in over 50 countries around the world to access market, technology, and competitive intelligence as well as patent insights needed to take products from ideation to commercialization. The company was founded in 2007 and is headquartered in Singapore.
  • ShopBack — Latest discount coupons, promo codes & vouchers for your online shopping. Plus FREE cashback rewards from ShopBack Singapore. Best deals & promotions!
Show all investments...

SK Securities
VC Fund · Yongdungpo, Seoul-t'ukpyolsi, South Korea · 1 investments in Singapore Life Science startups

SK Securities is a South Korea-based financial service provider that specializes in the securities market. It primarily engaged in securities brokerage, dealing and underwriting businesses, covering stocks, futures, options, government bonds, corporate bonds, foreign exchanges, and financial derivative products. The company also involves in the investment banking business, which provides acquisition, project financing services, and wealth management services. SK Securities was founded in 1955.

Show more...

Investment focus

  • Industry: Information Technology, Health Care, Artificial Intelligence
  • Stage:Series A, Seed, Series B
  • Geography: South Korea, United States, Singapore

Investor stats

  • Total investments: 55
  • Round size: Seed $316k–$2.2M; Series A $1.5M–$24M; Series B $5.7M–$24M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • InnoDtech — InnoDtech creates AI dental diagnostics and clear orthodontic aligners using 3D imaging, modeling, and personalized treatment planning.
  • HiveLab — HiveLab is a graphic design and advertising company.
  • Buysell Standards — Buysell Standards is the provider of manpower supply and employment arrangement services.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Alameda Research
VC Fund · Central and Western, Hong Kong Island, Hong Kong · 1 investments in Singapore Life Science startups

Alameda Research is a quantitative cryptocurrency trading firm that provides liquidity in cryptocurrency and digital assets markets. It was founded in 2017 and is headquartered in Central and Western, Hong Kong.

Show more...

Investment focus

  • Industry: Blockchain, Cryptocurrency, Financial Services
  • Stage:Seed, Venture - Series Unknown, Series A
  • Geography: United States, Singapore, United Kingdom

Investor stats

  • Total investments: 327
  • Round size: Seed $1M–$8M; Series A $2.7M–$35M; Venture - Series Unknown $250k–$40M
  • Lead/follow: 38% lead, 62% follow

Portfolio highlights

  • 3Commas — 3Commas develops a crypto-asset management tool for tracking investments and exchanges in a unified platform. It provides access to a unified dashboard as the central hub for trading and portfolio management execution.
  • Fuel Labs — At Fuel, we are building the fastest execution layer for the modular blockchain stack.
  • Optim Finance — Optim Finance provides investment tools that optimize yield on digital assets. Their financial primitives enable users to rent ADA delegation rights to power novel use cases such as SPO loans, leverage into ISOs, and initial bonds.
Show all investments...

Shinhan Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in Singapore Life Science startups

Shinhan Investment Corp. is a financial services company based out of 여의대로 70, 영등포구, 서울특별시, South Korea.

Show more...

Investment focus

  • Industry: Health Care, Manufacturing, Information Technology
  • Stage:Series A, Series B, Series C
  • Geography: South Korea, United States, Bermuda

Investor stats

  • Total investments: 41
  • Round size: Series A $1.7M–$23M; Series B $20k–$52M; Series C $8M–$106M
  • Lead/follow: 22% lead, 78% follow

Portfolio highlights

  • Inocras — Unlock the potential of a Whole Genome Sequencing Test with Inocras. Transforming diagnosis and treatment for cancer and rare diseases.
  • Sensor Tower — Sensor Tower provides market intelligence and analytics for the mobile app economy through their software suite. It serves independent and Fortune 500 customers alike, spanning the mobile games, travel, music, finance, eCommerce, and entertainment markets. Our suite consists of free, SMB, and Enterprise level solutions including Store Intelligence,Usage Intelligence, Ad Intelligence, and App Intelligence.
  • Woori Technology — We, Woori Technology, are trying our best to satisfy customers with continuous R&D and innovation.
Show all investments...

The Venture Collective
VC Fund · New York, New York, United States · 1 investments in Singapore Life Science startups, 8 in the past 12 months

An early-stage venture firm backing founders transforming legacy industries: industrial, energy and AI infrastructure, healthcare and applied bio, aerospace and defense.

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Artificial Intelligence
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 58
  • Round size: Seed $2.7M–$20M; Pre-Seed $410k–$1.9M; Series A $10M–$52M
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • Wizard Wellness — Wizard Wellness is a drug-free allergy care brand reimagining sinus health through nasal microbiome science. It develops wellness-focused products like probiotic nasal sprays, inhalers, oral strips, and sinus rinse kits designed to support nasal balance and reduce irritation from allergens. Founded in 2025, the company blends skincare-styleroutines with biotech-inspired ingredients to deliver daily, non-medicated allergy relief and long-term nasal wellness.
  • Universal Quantum — Universal Quantum is building quantum computers to tackle real-world problems that would take today’s fastest supercomputers billions of years to solve.
  • Eterna Regeneratives — Eterna Regeneratives develops regenerative biomaterials for mineralisation and tissue regeneration.
Show all investments...

Altara Ventures
VC Fund · Singapore, Central Region, Singapore · 1 investments in Singapore Life Science startups

Singapore-based venture firm backing Series A & B companies across Southeast Asia. Built by operators for founders who understand the long climb. Global perspective, local instincts.

Show more...

Investment focus

  • Industry: FinTech, Information Technology, Banking
  • Stage:Series A, Series B, Series C
  • Geography: Indonesia, Singapore, Philippines

Investor stats

  • Total investments: 25
  • Round size: Series A $4.5M–$21M; Series B $3.9M–$40M; Series C $12M–$70M
  • Lead/follow: 52% lead, 48% follow
  • Last fund: Likely still investing — raised $130M in 2022

Portfolio highlights

  • Saturdays — Shop for premium quality glasses at affordable prices with free shipping and 30-day return policy. Find your perfect pair with SATURDAYS LIFESTYLE.
  • Netbank — Netbank provides various banking solutions like alternative lenders, payment solutions, neobanks, and wallets.
  • PolicyStreet — Renew your insurance and road tax instantly, hassle-free. We're the BEST, but don't just take our word for it. See what our happy customers have to say!
Show all investments...

Hana Financial Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in Singapore Life Science startups

Hana Financial Investment Company Limited offers brokerage, securities dealing, underwriting, mutual funds, and online trading services

Show more...

Investment focus

  • Industry: Biotechnology, Information Technology, Artificial Intelligence
  • Stage:Series A, Series B, Seed
  • Geography: South Korea, Singapore, India

Investor stats

  • Total investments: 93
  • Round size: Seed $213k–$3.3M; Series A $2M–$26M; Series B $1.7M–$28M
  • Lead/follow: 13% lead, 87% follow

Portfolio highlights

  • Trustay — Trustay is a real estate asset management company.
  • earlysloth — Earlysloth is an AI based survey on the messenger for the enterprise.
  • Kimu Studio — Kimu discovers servant artists, plans education and exhibitions with the artist's unique sensibility.
Show all investments...

Openspace Capital
VC Fund · Singapore, Central Region, Singapore · 1 investments in Singapore Life Science startups

Openspace Ventures is a leading venture capital firm finding and backing Southeast Asian companies creating a transformative impact where tech meets life.

Show more...

Investment focus

  • Industry: E-Commerce, Financial Services, Software
  • Stage:Series A, Series B, Seed
  • Geography: Singapore, Indonesia, Philippines

Investor stats

  • Total investments: 137
  • Round size: Seed $2.6M–$13M; Series A $1.7M–$20M; Series B $10M–$35M
  • Lead/follow: 39% lead, 61% follow
  • Last fund: Likely still investing — raised $25M in 2022

Portfolio highlights

  • Every Half Coffee Roasters — Roasting & Brewing finest quality of specialty coffee bean from Vietnam and the world. We believe that every half bean has its soulmate. Let's find yours
  • Eunice — Eunice is an AI-powered due diligence and monitoring company built for institutional investors who cannot afford to get the details wrong.
  • Video Rebirth — Video Rebirth Limited is a private limited company that is established with shares.
Show all investments...

Seeds Capital
VC Fund · Singapore, Central Region, Singapore · 1 investments in Singapore Life Science startups

Catalysing smart monies into Singapore-based, early-stage technology startups.

Show more...

Investment focus

  • Industry: Biotechnology, Artificial Intelligence, Health Care
  • Stage:Seed, Series A, Series B
  • Geography: Singapore, United States, Hong Kong

Investor stats

  • Total investments: 150
  • Round size: Seed $767k–$6.8M; Series A $2.4M–$21M; Series B $5M–$45M
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • Nexstrom — Nexstrom is a semiconductor technology company developing wafer-scale 2D semiconductor technology and manufacturing systems for next-generation computing. Its technology is designed to address the high transistor density and energy efficiency requirements of AI infrastructure, supporting the development of advanced computing hardware for AI and other applications.
  • Respiree — They offer platforms that are able to report clinical deterioration and provide recommended interventions with post-monitoring.They work in the health care industry, just like you. We take the time to get to know you, and we always keep your best interests in mind when adding and adjusting products in our catalog.
  • Protuoso Biosciences — Protuoso Bio is a pioneering biotechnology company developing Next-Gen MUXBODIES for Complex Diseases. We leverage AI-driven protein engineering and synthetic biology to advance innovative oncology drug research.
Show all investments...

Nestle
VC Fund · Vevey, Vaud, Switzerland · 1 investments in Singapore Life Science startups

Nestle manufactures and sells food and beverages for several countries. It has generated more than CHF 90 billion in annual revenue. Its diverse product portfolio includes brands such as Nestle, Nescafe, Perrier, Pure Life, and Purina. Nestle also owns just over 23% of French cosmetics firm L'Oréal. It has a vast portfolio of global products,with 34 brands each achieving more than CHF 1 billion in sales annually and a geographic presence that spans 189 countries.

Show more...

Investment focus

  • Industry: Food and Beverage, Health Care, Food Processing
  • Stage:Private Equity, Corporate Round, Grant
  • Geography: United States, United Kingdom, Germany

Investor stats

  • Total investments: 21
  • Round size: Grant $6k–$150k; Private Equity $130M–$4.2B; Corporate Round $100M–$229M
  • Lead/follow: 62% lead, 38% follow

Portfolio highlights

  • Drools — Discover Drools, the best dog food brand offering premium nutrition for your furry friend. Explore our range of healthy, vet-recommended dog food to keep your pet happy and healthy.
  • Wonder — Introducing a new kind of home dining experience. Currently available in areas of New Jersey.
  • Hsu Fu Chi — Hsu Fu Chi is a confectionery company that manufactures various confectionaries, biscuits, chocolates, jellies, sachima, and snacks.
Show all investments...

KT Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in Singapore Life Science startups, 7 in the past 12 months

KT Investment, established in 2015 as the venture capital arm of KT Group, is dedicated to driving social impact while achieving maximum investment returns. We stand with founders every step of the way, providing the support and resources necessary to transform innovative ideas into impactful ventures. By partnering with promising startups and venture companies, we create win-win opportunities that pave the way for long-term success. With a global perspective, we actively seek value-driven investments that shape the future.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Software, Information Technology
  • Stage:Series A, Series B, Series C
  • Geography: South Korea, United States, Singapore

Investor stats

  • Total investments: 88
  • Round size: Series A $2M–$26M; Series B $6.7M–$124M; Series C $8.3M–$109M
  • Lead/follow: 6% lead, 94% follow

Portfolio highlights

  • Nums AI — Meet Causilo. A new foundation for the world's data.
  • Enhans — Viralpick provides IT services for organizations including data analysis, automation, acquisition, and advertising services.
  • MangoBoost — Data Processing Unit (DPU) is a next-generation server accelerator designed to orchestrate various intra-server devices (e.g., CPU, GPU, SSD, NPU, NIC). By maximizing the datacenter’s overall performance and cost efficiency, DPU is now considered as the most important HW/SW solution to realize the next-generation extreme-scale AI serverinfrastructure. However, despite its critical necessity from the datacenter and AI infrastructure, there is no market-leading DPU solution which can meet the customer’s actual demand due to its HW/SW complexity and the application/model heterogeneity. MangoBoost is currently the world’s most highly recognized DPU startup located in US and Korea. We provide the world’s most advanced and flexible DPU HW/SW solutions in order to fully satisfy the needs of various customers. Our DPU HW is fully composable by integrating its rich set of DPU features to construct our customer-optimal DPUs. At the same time, our DPU SW enables to seamlessly deploy the solution to any customer environment. As a result, our DPU solutions are considered very promising to realize the next-generation AI/datacenter infrastructure, and thus they are currently evaluated at various global-leading companies. MangoBoost was founded in early 2022 to commercialize 7 year of top-tier DPU research outcomes achieved at Seoul National University (e.g., many full-system DPU prototypes, many ISCA/MICRO/ASPLOS/OSDI/ATC papers). The current team consists of 45+ system engineers including ~20 top-tier PhDs from Carnegie Mellon University, Seoul National University, POSTECH, U Toronto, and ~20 industry experts from Intel, Microsoft, Samsung, and Naver.
Show all investments...

Prox Ventures
VC Fund · Shanghai, Shanghai, China · 1 investments in Singapore Life Science startups

Proxima Ventures focuses in the healthcare industry, supporting outstanding enterprises with innovative technologies or service models that have tremendous potential. They manage multiple funds in RMB and US dollar, covering from seed to growth stages. Their team members with multidisciplinary backgrounds and resourceful networks, have many years of remarkable venture capital experience and achievements. They believe that active and effective collaboration with entrepreneurs will make substantial economic returns while bring meaningful improvements in public health.

Show more...

Investment focus

  • Industry: Medical, Biotechnology, Health Care
  • Stage:Seed, Series A
  • Geography: China, United States, United Kingdom

Investor stats

  • Total investments: 83
  • Round size: Seed $2.5M–$30M; Series A $3M–$28M
  • Lead/follow: 18% lead, 82% follow

Portfolio highlights

  • BCI-Sonics — BCI-Sonics is an innovative medtech company developing non-invasive brain-computer interface solutions using advanced transcranial focused ultrasound (tFUS) technology. The company builds a next-generation therapeutic platform enabling precise neuromodulation to treat central nervous system disorders. BCI-Sonics develops low-intensity focusedultrasound technology that non-invasively stimulates deep brain regions with high precision. They combine ultrasound engineering and neuroscience to interface safely and effectively with the human brain without surgery. The company is creating an AI ultrasound brain-computer interface platform for therapeutic neuromodulation applications.
  • Bluesail Surgical — Bluesail Surgical is a surgical device company that specializes in the development of innovative surgical instruments for cardiovascular and cerebrovascular treatments.
  • Kingsung Medical Group — Kingsung Medical Group operates under the Mission “Simplify Surgery, Beautiful Life,” with its innovation centered on four core technology platforms at its Tianjin base: Mechanical Design, Polymer Materials, Biodegradable Magnesium Alloys, and Collagen Biomaterials. These platforms have enabled the development of pioneering medical devices,including microvascular anastomosis devices and neural tube. In particular, the Group’s biodegradable magnesium alloy technology is spearheading the advancement of next-generation orthopedic implants. Kingsung’s technological capabilities are evidenced by a portfolio of over 190 patents and its recognition as a National Key Enterprise. The Group also actively contributes to the industry as a standing council member of the Microsurgery Branch of the China Association of Medical Devices Industry and a member of the Chinese Society for Biomaterials.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
K3 Ventures
VC Fund · Singapore, Central Region, Singapore · 1 investments in Singapore Life Science startups

K3 Ventures provides venture capital for technology startups in various sectors such as finance, education, healthcare, food and agriculture and others. The firm is headed by Kuok Meng Xiong.

Show more...

Investment focus

  • Industry: Financial Services, FinTech, Software
  • Stage:Series A, Seed, Venture - Series Unknown
  • Geography: Singapore, United States, Indonesia

Investor stats

  • Total investments: 108
  • Round size: Seed $1.2M–$20M; Series A $2M–$100M; Venture - Series Unknown $1M–$2.5B
  • Lead/follow: 9% lead, 91% follow
  • Last fund: May invest from a new fund soon — raised $147M in 2021

Portfolio highlights

  • iEduGPT — iEduGPT is an AI-powered learning platform based in Singapore that offers personalized, adaptive learning solutions for professional and academic exam preparation. It leverages artificial intelligence to analyze individual learners' strengths and knowledge gaps and create optimized study paths. The platform aims to transform exam preparationby making learning smarter, more efficient, and tailored to each user’s unique needs, covering certifications in finance, academics, and languages.
  • Rekosistem — Rekosistem is a Clean- & Climate-Tech Company that enables circular economy implementation in the waste supply chain by leveraging proprietary waste management operation systems to transform waste into recycled materials and renewable resources.
  • Octopus Power — Octopus Power develops physics-based artificial intelligence systems focused on physical AGI, enabling machines to perceive, reason, and act within real-world environments. The company builds models that integrate physical laws with data-driven learning to support embodied intelligence, allowing systems to interact with and adapt to dynamicphysical conditions. Its technology is designed to move beyond purely digital AI by incorporating simulation, control systems, and real-world feedback loops into intelligent decision-making.The platform supports applications in robotics, industrial automation, and complex physical systems where understanding motion, force, and environmental constraints is essential. It leverages continuous learning mechanisms that allow systems to evolve over time, improving performance through interaction and data accumulation. Octopus Power also develops infrastructure for training and deploying these models, including simulation environments and tools for integrating AI with physical hardware.
Show all investments...

Vertex Ventures Southeast Asia & India
VC Fund · Singapore, Central Region, Singapore · 1 investments in Singapore Life Science startups

Vertex Ventures Southeast Asia and India invests in high-growth start-ups seeking their first round of institutional venture capital funding in Southeast Asia and India, with a primary focus on Singapore, India, Indonesia, Thailand and other emerging hubs of innovation across the region. It has a long and strong track record of investing in early-stage startups and building champions like Grab, Patsnap, 17Live, Nium, FirstCry, Licious, AsianParent, Validus, Warung Pintar, and others.

Show more...

Investment focus

  • Industry: E-Commerce, Financial Services, FinTech
  • Stage:Series A, Series B, Seed
  • Geography: India, Singapore, Indonesia

Investor stats

  • Total investments: 145
  • Round size: Seed $2.2M–$6.9M; Series A $3.6M–$15M; Series B $7.5M–$40M
  • Lead/follow: 33% lead, 67% follow
  • Last fund: Likely still investing — raised $541M in 2023

Portfolio highlights

  • Dtcpay — dtcpay is a leading provider of digital payment solutions, pioneering the integration of cryptocurrency acceptance into traditional financial systems.
  • Drylab AI — Drylab is a biotechnology software company that develops AI tools for biomedical research and bioinformatics. Its platform enables scientists to analyze biological and clinical datasets, conduct research, automate analytical workflows, and access a built-in coding environment for data processing and reproducible analyses. The platform supports multiple data types, including genomics, transcriptomics, proteomics, imaging, spatial omics, and clinical datasets, and is designed for researchers, laboratories, and life science organizations.
  • Quantified Energy Labs — Quantified Energy Labs (QE LABS) is a deep tech spinoff company from the Solar Energy Research Institute of Singapore/National University of Singapore. We are a team of professionals with expertise in the fields of solar energy, computer vision, and drone technology.
Show all investments...

Hatcher+
VC Fund · Singapore, Central Region, Singapore · 1 investments in Singapore Life Science startups

Hatcher+ is a data-driven venture capital firm that uses AI and machine learning-based technologies to identify early-stage opportunities in partnership with leading accelerators and investors, worldwide.

Show more...

Investment focus

  • Industry: Software, Information Technology, Health Care
  • Stage:Pre-Seed, Seed, Convertible Note
  • Geography: United States, Italy, Australia

Investor stats

  • Total investments: 195
  • Round size: Seed $50k–$1.5M; Pre-Seed $50k–$1.2M
  • Lead/follow: 61% lead, 39% follow

Portfolio highlights

  • Inaam — inaam is an Australian impact investing app. Pick five themes, customise them and read every company you hold by name. Flat $10 a month, $100 minimum to invest.
  • M-Based — M-Based develops next-generation biomaterials using mushroom, redefining sustainability in design and materials.
  • Kybele's Garden — Kybele's Garden focus on algae-based bioponics and algae fermentation methods. Their differentiation strategy boosts harvest yield, source efficiency, and functional content, while improving sensory attributes and shelf life. These technologies can be used in agrifood and skin care, and integrated into existing producers' systems.
Show all investments...

Elev8.VC
VC Fund · Singapore, Central Region, Singapore · 1 investments in Singapore Life Science startups

Deep Dive Into Deep Tech

Show more...

Investment focus

  • Industry: Health Care, Biotechnology, Medical
  • Stage:Seed, Series A
  • Geography: Singapore, United States, Germany

Investor stats

  • Total investments: 27
  • Round size: Seed $1M–$4.8M; Series A $1.7M–$13M
  • Lead/follow: 37% lead, 63% follow
  • Last fund: Likely actively investing — fresh fund, raised $30M in 2025

Portfolio highlights

  • Polybee — Polybee develops autonomous drone systems designed for agricultural applications. They focus on automating yield forecasting and pollination using drones, computer vision, and artificial intelligence. Their technology aims to reduce uncertainty in agriculture by providing solutions for seed companies, vertical farming operations, and greenhousecooperatives. Polybee's innovations are particularly useful in environments.
  • N&E Innovations — Our Kitchen solutions include our heavy duty countertop laminates and surface spray coatings that provide a 90-day long protection that is effective against
  • 2Strands Biosciences — 2Strands is an early-stage precision diagnostic company developing an allele specific enrichment technology for ultrasensitive MRD monitoring from ctDNA.
Show all investments...

Amgen Ventures
VC Fund · San Francisco, California, United States · 1 investments in Singapore Life Science startups

Amgen Ventures is a venture capital investment arm of Amgen Inc. specializing in investments in early and later stage companies. The firm primarily invests in the biotechnology sector with a focus on discovering and developing human therapeutics with a focus on oncology, inflammation, hematology, nephrology, metabolic disorders, neuroscience, and cardiovascular therapeutics. In oncology and hematology it focuses on novel therapeutics including signal transduction, cell cycle, and apoptosis; hematopoiesis including anemia, neutropenia, and stem cell mobilization; and supportive care including mucositis and cachexia. In nephrology the firm focuses on renal failure and hyperparathyroidism. For inflammation the firm focuses on rheumatoid arthritis, psoriasis, systemic lupus erythematosus, inflammatory bowel disease, multiple sclerosis, asthma and COPD, and osteoarthritis. Under cardiovascular, it focuses on acute coronary syndromes, dyslipidemia, and heart failure and under metabolic disorders it focuses on diabetes, metabolic syndrome, and osteoporosis. The focus on neuroscience included pain including neuropathic and inflammatory, alzheimer's disease, parkinson's disease, sleep disorder, cognition, and schizophrenia. In discovery research and technology the firm focuses on early-stage drug discovery collaborations, innovative chemical entity collections, diagnostics and biomarkers, novel antibody platforms, assay biologicals and devices, and target-focused structural biology and computational tools. It primarily invests in the North America, Europe, and the United Kingdom. The firm typically invests between $2 million and $3 million per transaction and may invest up to $10 million per company. It prefers to have an ownership stake of less than 15 % in its portfolio companies. Amgen Ventures was founded in 2004 and is based in San Francisco, California with additional offices in Seattle, Washington; Thousand Oaks, California; and Cambridge, Massachusetts.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series B, Series A, Series C
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 121
  • Round size: Series A $4.4M–$53M; Series B $8.5M–$114M; Series C $19M–$80M
  • Lead/follow: 12% lead, 88% follow
  • Last fund: May invest from a new fund soon — raised $100M in 2012

Portfolio highlights

  • TileDB — TileDB is the foundational database designed for scientific discovery. Powered by shape-shifting arrays, TileDB resolves the complexity of multimodal data like population genomics, proteomics, single-cell and bioimaging so scientists and data teams can effectively glean biologically meaningful insights that drive drug and target discovery.
  • BigHat Biosciences — We use machine learning and synthetic biology to design and engineer antibody therapeutics.
  • Soufflé Therapeutics — Soufflé Therapeutics is a biotechnology company specializing in the development of nucleic acid medicines designed for precise delivery and targeting of disease-causing cells. The company's mission is to create potent, precise, and safe medicines that can be tailored for a broad range of diseases by leveraging breakthroughs in genetic medicineand drug delivery technology.
Show all investments...

Arche Investment
VC Fund · 1 investments in Singapore Life Science startups

Arche Investment is an investment firm.

Show more...

Investment focus

  • Industry: Biotechnology, Pet, Apps
  • Stage:Series B, Series A
  • Geography: South Korea, Singapore

Investor stats

  • Total investments: 5
  • Round size: Series B $16M–$27M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • Cerecin — Cerecin is a healthcare company that develops novel evidence-based therapeutics and products that aim to help people.We develop novel evidence-based therapeutics and products that aim to help millions of people. These solutions are designed to target conditions ranging from memory impairment to Alzheimer’s disease and other devastatingneurological diseases.
  • Kasa — Kasa is a financial service platform that allows people to invest in commercial real estate.
  • Newracle Genetics — Newracle Genetics is a bio venture company that develops gene therapy products for neurological diseases.
Show all investments...

KB Financial Group
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in Singapore Life Science startups

KB Financial Group is Korea’s leading financial institution with the largest customer base and the most extensive branch network in the country. With total assets exceeding US$342 billion, the Group wields a solid capital prowess and enjoys a strong brand loyalty. As of December 2012, the Group has ten domestic subsidiaries--banking, credit cards,securities, life insurance, asset management, real estate trust, venture capital, credit information, data system, and savings bank--and four overseas subsidiaries in Hong Kong, England, Cambodia, and China.KB Financial Group was established in September 2008 with extensive stock transfers from major subsidiary companies. The Group’s establishment was to better deal with such fundamental changes in the financial markets at home and abroad as the rapid globalization of financial service, a declining profitability of traditional banking operations, new industry regulations, and an increasing demand for comprehensive financial services.

Show more...

Investment focus

  • Industry: Financial Services, Software, SaaS
  • Stage:Series A, Series B, Series D
  • Geography: South Korea, India, Vietnam

Investor stats

  • Total investments: 14
  • Round size: Series A $1M–$45M; Series B $7.8M–$128M; Series D $182M–$220M
  • Lead/follow: 21% lead, 79% follow

Portfolio highlights

  • Nitra — Nitra offers expense management software that integrates with the banks to provide innovative loan products.
  • Wavebridge — Wavebridge is a top-tier institutional digital asset company with expertise in both traditional and crypto finance. The company was established in November 2018 to provide a comprehensive suite of investment solutions utilizing its data processing and AI technology.
  • Ohouse — No.1 Interior Onestop Platform
Show all investments...

Enterprise Singapore
VC Fund · Singapore, Central Region, Singapore · 1 investments in Singapore Life Science startups

Enterprise Singapore is a government agency that supports enterprise development. The company works with committed companies to build capabilities, innovate and internationalize. Enterprise Singapore also supports the growth of Singapore as a hub for global trading and startups. As the national standards and accreditation body, the company continues to build trust in Singapore’s products and services through quality and standards. To enable businesses navigate today’s enterprise landscape, Enterprise Singapore adopts a company-centric approach. Enterprise Singapore do so, by providing programmes and support catered to your company’s stage of growth, the industry you are in, and the overseas markets of your interest.

Show more...

Investment focus

  • Industry: Information Technology, Software, Artificial Intelligence
  • Stage:Grant, Seed, Pre-Seed
  • Geography: Singapore, United States, United Kingdom

Investor stats

  • Total investments: 52
  • Round size: Seed $300k–$1.8M; Grant $22k–$585k; Pre-Seed $40k–$300k
  • Lead/follow: 19% lead, 81% follow

Portfolio highlights

  • Oncoshot — Oncoshot helps patients, caregivers and oncologists find cancer clinical trials anywhere in the world. In this fast-changing landscape of cancer care, we want to solve the problem of access to clinical trials. Our technology allows patients to share their data with trial institutes and sponsors and receive an immediate response, shortening theclinical trial search from weeks to minutes. Our goal is to empower patients to take control of their cancer journey and expand their options.We are a private company headquartered in Singapore and our activities are regulated by the Ministry of Health (Singapore) and Health Services Authority (HSA) Singapore.
  • Pride Health — Access trusted doctors, e-prescriptions, and discreet medication delivery. Safe, convenient, and judgment-free.
  • 2Strands Biosciences — 2Strands is an early-stage precision diagnostic company developing an allele specific enrichment technology for ultrasensitive MRD monitoring from ctDNA.
Show all investments...

Gaorong Capital
VC Fund · Wangjing, Beijing, China · 1 investments in Singapore Life Science startups

Investors of Gaorong Capital include world-class sovereign wealth funds, university endowment funds, family foundations, pension funds and fund of funds, as well as successful entrepreneurs, including founders and managements of Tencent, Alibaba, Baidu, JD, Xiaomi, Focus Media and VIPShop. They will provide with valuable industry resources, entrepreneurial experience, and global perspectives.

Show more...

Investment focus

  • Industry: Artificial Intelligence, Information Technology, Software
  • Stage:Series A, Series B, Seed
  • Geography: China, United States, Singapore

Investor stats

  • Total investments: 371
  • Round size: Seed $2.8M–$100M; Series A $1.6M–$75M; Series B $14M–$110M
  • Lead/follow: 29% lead, 71% follow
  • Last fund: Likely still investing — raised $185M in 2022

Portfolio highlights

  • Anew Labs — Anew Labs develops generative AI platforms and foundation models to accelerate drug discovery, including protein structure prediction, antibody design, and cellular dynamics forecasting. The company integrates its computational engines with experimental feedback to advance pipelines targeting diseases like inflammatory conditions. Its business model centers on side-by-side collaboration between machine learning researchers and biotechnology experts to create synthesizable molecular pathways and clinical candidates.
  • Cascade — Cascade produces novel medications that target nuclear receptors for treating metabolic disorders and inflammation.
  • Sequence Technology — Sequence Technology emphasizes in the production of polymer materials used in the semiconductor manufacturing process.
Show all investments...

10X Capital
VC Fund · New York, New York, United States · 1 investments in Singapore Life Science startups

10X invests across the capital structure, alongside the world's top technology investors. They align Wall Street and Silicon Valley by bringing institutional capital to high growth ventures in private and public markets, helping founders and investors achieve scale and liquidity while retaining upside and control.10X was founded in 2004 andis based in New York.

Show more...

Investment focus

  • Industry: Software, Health Care, FinTech
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Canada, United Kingdom

Investor stats

  • Total investments: 264
  • Round size: Seed $1.2M–$6M; Pre-Seed $800k–$5M; Series A $4M–$36M
  • Lead/follow: 3% lead, 97% follow
  • Last fund: May invest from a new fund soon — last raise in 2021

Portfolio highlights

  • Portal — Build next-generation cell engineering and drug discovery workflows with Portal mechanoporation for broad intracellular delivery across cells and cargoes.
  • CEA Industries — CEA Industries (NASDAQ: BNC) is a publicly traded company pursuing a BNB-focused digital asset treasury strategy.
  • Host Digital — Host Digital is an infrastructure company that develops and operates data centers for AI and high-performance computing.
Show all investments...

Access 48,091 investors

822 industries, 177 countries. Updated daily. Emails and phones included.

Browse database — It's Free!
Animoca Brands
VC Fund · Cyberport, Hong Kong Island, Hong Kong · 1 investments in Singapore Life Science startups, 25 in the past 12 months

Animoca Brands is a metaverse and gaming venture capital firm that focuses on driving digital property rights to gamers and internet users through NFTs. It utilizes gamification and blockchain to develop and market a portfolio of mobile applications, games, and additional products oriented to educational learning to ensure transparency, security, and new business models.

Show more...

Investment focus

  • Industry: Blockchain, Gaming, Cryptocurrency
  • Stage:Seed, Series A, Pre-Seed
  • Geography: United States, Singapore, United Kingdom

Investor stats

  • Total investments: 519
  • Round size: Seed $1.3M–$10M; Pre-Seed $100k–$5M; Series A $5M–$40M
  • Lead/follow: 44% lead, 56% follow

Portfolio highlights

  • Superlogic — OneOf is the mass-consumer Web3 company connecting the next 100M non-crypto-native fans to iconic brands, artists, and athletes. OneOf technology enables global brands and enterprises to reimagine commerce, loyalty and engagement, allowing consumers to seamlessly collect or trade digital assets with no prior crypto expertise. Deeply committed to a sustainable and inclusive blockchain future, minting digital assets on OneOf's platform uses up to 2 million times less energy than previous generation proof-of-work networks, and costs up to 99% less in gas fees. A leader in diversity, over 80% of the collections curated by OneOf come from minority or female creators.
  • PERPTools — PERPTools combines crypto perpetual trading with activity points and risk-free market predictions.
  • Slinky Network — Slinky Network provides an on-chain marketplace and payment protocol that connects AI agents and applications with third-party APIs. The company offers the SlinkyLayer platform, which wraps developer endpoints as discoverable skills and exposes them through an x402 pay-per-execution interface. Each API call triggers a non-custodial on-chainmicropayment, settling in the same request loop using networks such as Base and BNB Chain. Developers set prices, earn a defined revenue share, and receive instant payouts to their wallets without subscriptions or custodial holds. AI agents authenticate via wallet signatures, enabling autonomous, machine-to-machine access and payment without traditional logins or credit cards. The platform also records call ratings on-chain to provide portable, verifiable reputation for services.
Show all investments...

NPR Holdings
VC Fund · Whitmore Lake, Michigan, United States · 1 investments in Singapore Life Science startups

NPR Holdings

Show more...

Investment focus

  • Industry: Medical, Life Science, Biotechnology
  • Stage:Venture - Series Unknown
  • Geography: Singapore

Investor stats

  • Total investments: 1
  • Lead/follow: 0% lead, 100% follow

Portfolio highlights

  • ImmunoScape — ImmuniScape discovers and develops novel TCR-based therapeutics against solid tumors
Show all investments...

Lightstone Ventures
VC Fund · Menlo Park, California, United States · 1 investments in Singapore Life Science startups

Lightstone Ventures is a global venture capital firm that invests in personalized medicines and targeted therapeutics. Lightstone Ventures was founded in 2012 by the General Partners and other key members of the life science teams of Advanced Technology Ventures (ATV) and Morgenthaler. The firm was formed to capture the upside of investing in breakthrough life science companies during a time of unique opportunity in space.

Show more...

Investment focus

  • Industry: Biotechnology, Health Care, Therapeutics
  • Stage:Series A, Series B, Series C
  • Geography: United States, Ireland, India

Investor stats

  • Total investments: 88
  • Round size: Series A $20M–$95M; Series B $18M–$100M; Series C $20M–$105M
  • Lead/follow: 25% lead, 75% follow
  • Last fund: May invest from a new fund soon — raised $375M in 2021

Portfolio highlights

  • Cerevance — Cerevance is a biotechnology company that develops novel therapeutics for neurological diseases, including chronic neurodegenerative conditions such as Alzheimer's disease, Parkinson's disease, frontotemporal dementia, and amyotrophic lateral sclerosis. Using a large and growing repository of over 15,000 human brain tissue samples, thecompany generates an unprecedented level of expression and epigenetic data, enabling the company to identify the most promising targets for the next generation of treatments for CNS disorders.
  • Psivant Therapeutics — PsiThera is advancing programs across multiple targets from the TNF superfamily and beyond, where no oral therapies currently exist.
  • Crystalys Therapeutics — Crystalys Therapeutics is a clinical-stage biopharmaceutical company transforming the treatment of gout.
Show all investments...

Medici Investment
VC Fund · Seoul, Seoul-t'ukpyolsi, South Korea · 1 investments in Singapore Life Science startups

Venture Capital firm in South Korea.

Show more...

Investment focus

  • Industry: Biotechnology, Information Technology, Software
  • Stage:Series A, Series C, Seed
  • Geography: South Korea, Canada, Singapore

Investor stats

  • Total investments: 40
  • Round size: Seed $913k–$3.7M; Series A $861k–$18M; Series C $2.9M–$250M
  • Lead/follow: 20% lead, 80% follow

Portfolio highlights

  • MID — MID specializes in the development, testing, and production of space-related components.
  • RebuilderAI — A new way to bring imagination into the real world
  • Destin Power — Destin Power manufactures power conditioning products designed to improve energy management and safety. The company created the ESS system by utilizing core power electronics technology such as control technology for energy storage systems, static and dynamic grid support technology, and micro-grid inverter technology.
Show all investments...

M Capital Partners
VC Fund · Toulouse, Midi-Pyrenees, France · 1 investments in Singapore Life Science startups

M Capital is an independent investment company with +€500m AuM. A unique hub where entrepreneurs can have an equity finance and quasi-equity as well as a permanent support to accelerate their growth. In 2020, M Capital has funded over 200 French companies.

Show more...

Investment focus

  • Industry: Health Care, Software, Food and Beverage
  • Stage:Venture - Series Unknown, Seed
  • Geography: France, United States, Canada

Investor stats

  • Total investments: 113
  • Round size: Seed $1.1M–$5.4M; Venture - Series Unknown $1.2M–$5.6M
  • Lead/follow: 56% lead, 44% follow
  • Last fund: May invest from a new fund soon — last raise in 2019

Portfolio highlights

  • Haiku — Haiku is revolutionizing legal practice by placing artificial intelligence and data at the service of law.
The company's objective is to free lawyers from tedious research and writing tasks to assist them in all of their work and thus increase their productivity while preserving their expertise.
  • The Sanctuary Group — The Sanctuary Group provides aqua-cycling, indoor cycling, boxing bootcamp, yoga, dance cardio, HIIT workouts, and kids’ swim classes.
  • Ascendance — Sustainable flight solutions for today & tomorrow... because cleaner aviation can't wait. With Ascendance, Fly quieter, cleaner, further.
Show all investments...

Life Science VC funding in Singapore at a glance

Stats across 43 deals from 76 investors.

76
investors
in Singapore Life Science startups
43
deals
in Singapore Life Science startups
$7.2M
median round
in Singapore Life Science startups
53%
lead investors
lead at least one round
21%
Seed
most common funding stage

Access all 76 VC funds in Singapore Life Science startups.

Open List

FAQ

Is Shizune data fresh/accurate?

Shizune has monitored hundreds of funding sources since 2020.

Our investor database is updated every day, so investor data is always fresh.

All metrics are calculated from confirmed public rounds, so the data is accurate.

Can I download investor list?

To download the Life Science VC Funds in Singapore investor list, create a Shizune account. This investor list will be added to your saved investors and available for download in the export section.

You can also enrich the investor list with investor emails, phones, LinkedIns, and other contact data.

Can I access investor database?

To access all 76 VC funds investing in Singapore Life Science startups and 48,091+ more investors, create a Shizune account.

Shizune has a database of 48,091 investors. Our investor database is fresh and updated daily.

The Shizune investor database has information on investor investment focus, investor contact data, and full investor portfolio since 2020.

You can enrich with email and download the data.

Does Shizune have investor emails and contacts?

Shizune enriches investors with contact data that includes: email, phones, LinkedIn, socials, website, and others.

To guarantee the highest discovery rate, we search across 20+ contact search tools.

To maximize delivery rate and reduce bounce rate, we validate emails.

You can enrich your investor list with Shizune. Download it too.

What is Shizune?

Shizune is a 48,091 investor database updated daily.

With Shizune you can:

  • browse the database
  • use smart matching
  • enrich with emails
  • download

All you need to find investors for your startup.

Who is Shizune for?

Shizune is built for startup founders by startup founders.

If you are looking for funding for your startup, try the Shizune database — we have investors for every stage, industry, and country.

Is Shizune free?

Shizune is free forever. You can search and browse investors for free.

Email search and export are paid features.

For full info, visit our pricing.

Who built Shizune?

Shizune is built by founders with the goal of helping all founders raise funding no matter where they are.

Contact 100 investors today

Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.

Find investors — It's Free!

More investor lists

Broader lists